X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/leqembi-revenue-totaled-jpy-2-83-billion-in-the-first-quarter-2024--302126045.html
https://www.prnewswire.com/news-releases/bioarctic-and-eisai-sign-research-evaluation-agreement-regarding-ban2802-302122671.html
https://www.prnewswire.com/news-releases/the-nomination-committees-proposal-for-the-election-of-board-members-and-chairperson-of-the-board-in-bioarctic-ab-302118178.html
https://www.prnewswire.com/news-releases/bioarctics-focus-on-sustainable-innovation-qualifies-company-for-new-esg-responsibility-index-at-nasdaq-stockholm-302112747.html
https://www.prnewswire.com/news-releases/submission-of-leqembi-lecanemab-irmb-sbla-for-iv-maintenance-dosing-for-the-treatment-of-early-alzheimers-disease-to-the-us-fda-completed-302104249.html
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-does-not-refer-eisai-biogen-alzheimers-drug-meeting-notes-2024-03-22/
https://www.prnewswire.com/news-releases/bioarctic-professor-lars-lannfelt-awarded-fondation-recherche-alzheimers-european-grand-prix-for-his-contributions-to-science-and-treatment-of-alzheimers-disease-302092557.html
https://www.prnewswire.com/news-releases/bioarctic-new-data-on-lecanemab-presented-at-the-2024-adpd-congress-302085067.html
https://www.prnewswire.com/news-releases/bioarctics-partner-eisai-presents-updated-sales-simulation-for-leqembi-at-its-annual-press-conference-302082469.html
https://www.prnewswire.com/news-releases/sales-of-leqembi-totaled-1-1-billion-yen-in-the-fourth-quarter-2023--302054077.html
Market Place
Share 
